// App-Quantinova.ai

POS0152 (2022) : DIRECT AND INDIRECT EFFECT OF TNF INHIBITORS ON SPINAL MOBILITY IN PEOPLE WITH AXIAL SPONDYLOARTHRITIS AND THE MEDIATOR ROLE OF DISEASE ACTIVITY

Researchers

Presenter

  • A. S. Pinto

Principal Investigators

  • B. Yao

  • C. Harris

  • R. Hayward

  • A. Keat

  • P. Machado

Medical Centers

  • Unidade de Saúde Local da Guarda, Rheumatology Department, Guarda, Portugal

  • University of Oxford, Oxford, United Kingdom

  • Northwick Park Hospital, London North West University Healthcare NHS Trust, Rheumatology, London, Portugal

  • University College London, Centre for Rheumatology Research & MRC Centre for Neuromuscular Diseases, London, United Kingdom

Locations

  • Portugal

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

  • Ankylosing spondylitis

  • Spondyloarthritis

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved